These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 15711750)

  • 21. Effects of a snake venom metalloproteinase, triflamp, on platelet aggregation, platelet-neutrophil and neutrophil-neutrophil interactions: involvement of platelet GPIbalpha and neutrophil PSGL-1.
    Tseng YL; Lee CJ; Huang TF
    Thromb Haemost; 2004 Feb; 91(2):315-24. PubMed ID: 14961160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
    Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
    Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of verapamil on platelet aggregation and serum thromboxane synthesis in vitro and in vivo.
    Strano A; Davì G; Novo S; Custro N; Mattina A; Gallo V
    Int Angiol; 1985; 4(3):379-82. PubMed ID: 3913716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies.
    Sheu JR; Fong TH; Liu CM; Shen MY; Chen TL; Chang Y; Lu MS; Hsiao G
    Br J Pharmacol; 2004 Sep; 143(1):193-201. PubMed ID: 15289295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide.
    Rendu F; Bachelot C; Molle D; Caen J; Guez D
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S57-63. PubMed ID: 7508063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trastuzumab (herceptin), a humanized anti-Her2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cells.
    Molina MA; Codony-Servat J; Albanell J; Rojo F; Arribas J; Baselga J
    Cancer Res; 2001 Jun; 61(12):4744-9. PubMed ID: 11406546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro effects of gallopamil on platelet aggregation and thromboxane generation.
    Davì G; Novo S; Mattina A; Catalano I; Strano A
    Arzneimittelforschung; 1988 May; 38(5):698-9. PubMed ID: 3415711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propofol inhibits human platelet aggregation induced by proinflammatory lipid mediators.
    Fourcade O; Simon MF; Litt L; Samii K; Chap H
    Anesth Analg; 2004 Aug; 99(2):393-8, table of contents. PubMed ID: 15271713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of selective inhibition of the p38 MAP kinase pathway on platelet aggregation.
    Kuliopulos A; Mohanlal R; Covic L
    Thromb Haemost; 2004 Dec; 92(6):1387-93. PubMed ID: 15583748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. YD-3, a novel inhibitor of protease-induced platelet activation.
    Wu CC; Huang SW; Hwang TL; Kuo SC; Lee FY; Teng CM
    Br J Pharmacol; 2000 Jul; 130(6):1289-96. PubMed ID: 10903968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zinc-triggered induction of tissue plasminogen activator by brain-derived neurotrophic factor and metalloproteinases.
    Hwang IY; Sun ES; An JH; Im H; Lee SH; Lee JY; Han PL; Koh JY; Kim YH
    J Neurochem; 2011 Sep; 118(5):855-63. PubMed ID: 21615740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentiation of ADP-induced platelet aggregation by mercury compounds.
    Kostka B
    Thromb Res; 1990 Mar; 57(5):795-801. PubMed ID: 2339370
    [No Abstract]   [Full Text] [Related]  

  • 33. [The studies on the mechanism of platelet activation induced by exogenous arachidonic acid with special reference to intraplatelet Ca2+ mobilization].
    Koyama M
    Hokkaido Igaku Zasshi; 1994 Jul; 69(4):1044-56. PubMed ID: 7959585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production.
    Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC
    Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory mechanisms of activated matrix metalloproteinase-9 on platelet activation.
    Lee YM; Lee JJ; Shen MY; Hsiao G; Sheu JR
    Eur J Pharmacol; 2006 May; 537(1-3):52-8. PubMed ID: 16624282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification of aminophenyl mercuryacetate-activated human matrix metalloproteinase 1 and removal of the organomercurial in a single-step chromatography.
    Huse K; Wippich P; Gutknecht D; Aust G; Scholz GH
    Bioseparation; 1999; 7(6):281-6. PubMed ID: 10643638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levobupivacaine differentially suppresses platelet aggregation by modulating calcium release in a dose-dependent manner.
    Liou JT; Mao CC; Liu FC; Lin HT; Hung LM; Liao CH; Day YJ
    Acta Anaesthesiol Taiwan; 2012 Sep; 50(3):112-21. PubMed ID: 23026170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of recombinant human neutrophil collagenase by doxycycline is pH dependent.
    Smith GN; Brandt KD; Mickler EA; Hasty KA
    J Rheumatol; 1997 Sep; 24(9):1769-73. PubMed ID: 9292802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
    Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the molecular mechanism of mersalyl and 4-aminophenylmercuric acetate re-activation of trypsin-thiol complexes.
    Steven FS; Griffin MM
    Eur J Biochem; 1980 Aug; 109(2):567-73. PubMed ID: 7408902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.